These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1873479

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L, Petersen F, Flad HD, Brandt E.
    J Immunol; 1994 Dec 15; 153(12):5698-708. PubMed ID: 7989767
    [Abstract] [Full Text] [Related]

  • 3. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P, Evangelista V, Piccoli A, de Gaetano G, Walz A, Cerletti C.
    Thromb Haemost; 1996 Nov 15; 76(5):780-5. PubMed ID: 8950790
    [Abstract] [Full Text] [Related]

  • 4. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD, Baggiolini M, Walz A.
    Biochem J; 1991 May 01; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE, Ludwig A, Grimm TA, Lindner B, Flad HD, Brandt E.
    Blood; 2000 Nov 01; 96(9):2965-72. PubMed ID: 11049972
    [Abstract] [Full Text] [Related]

  • 6. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
    Schiemann F, Grimm TA, Hoch J, Gross R, Lindner B, Petersen F, Bulfone-Paus S, Brandt E.
    Blood; 2006 Mar 15; 107(6):2234-42. PubMed ID: 16317101
    [Abstract] [Full Text] [Related]

  • 7. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
    Cohen AB, Stevens MD, Miller EJ, Atkinson MA, Mullenbach G.
    Am J Physiol; 1992 Aug 15; 263(2 Pt 1):L249-56. PubMed ID: 1387511
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
    Walz A, Baggiolini M.
    J Exp Med; 1990 Feb 01; 171(2):449-54. PubMed ID: 2406364
    [Abstract] [Full Text] [Related]

  • 10. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ, Yoshimura T, Rot A, Noer K, Walz A, Baggiolini M, Walz DA, Goetzl EJ, Castor CW.
    J Leukoc Biol; 1991 Mar 01; 49(3):258-65. PubMed ID: 1997632
    [Abstract] [Full Text] [Related]

  • 11. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG, Lazar JB, Johnson PH, Edwards BF.
    J Mol Biol; 1997 Feb 21; 266(2):367-80. PubMed ID: 9047370
    [Abstract] [Full Text] [Related]

  • 12. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
    Tai PK, Liao JF, Hossler PA, Castor CW, Carter-Su C.
    J Biol Chem; 1992 Sep 25; 267(27):19579-86. PubMed ID: 1527075
    [Abstract] [Full Text] [Related]

  • 13. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
    Proudfoot AE, Peitsch MC, Power CA, Allet B, Mermod JJ, Bacon K, Wells TN.
    J Protein Chem; 1997 Jan 25; 16(1):37-49. PubMed ID: 9055206
    [Abstract] [Full Text] [Related]

  • 14. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
    Castor CW, Andrews PC, Swartz RD, Ellis SG, Hossler PA, Clark MR, Matteson EL, Sachter EF.
    Arthritis Rheum; 1993 Aug 25; 36(8):1142-53. PubMed ID: 8343190
    [Abstract] [Full Text] [Related]

  • 15. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR, Kuna P, Miragliotta GF, Kornfeld D, Baeza ML, Castor CW, Kaplan AP.
    J Allergy Clin Immunol; 1992 Mar 25; 89(3):666-72. PubMed ID: 1372016
    [Abstract] [Full Text] [Related]

  • 16. Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets.
    Castor CW, Walz DA, Ragsdale CG, Hossler PA, Smith EM, Bignall MC, Aaron BP, Mountjoy K.
    Biochem Biophys Res Commun; 1989 Sep 15; 163(2):1071-8. PubMed ID: 2783111
    [Abstract] [Full Text] [Related]

  • 17. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ, Leone JW, Reardon IM, Howe WJ, Asa D, Heinrikson RL, Ledbetter SR.
    J Biol Chem; 1995 Feb 17; 270(7):3268-77. PubMed ID: 7852412
    [Abstract] [Full Text] [Related]

  • 18. Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue-activating peptide CTAP III.
    Deutsch V, Bitan M, Friedmann Y, Eldor A, Vlodavsky I.
    Br J Haematol; 2000 Dec 17; 111(4):1180-9. PubMed ID: 11167759
    [Abstract] [Full Text] [Related]

  • 19. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
    Castor CW, Walz DA, Johnson PH, Hossler PA, Smith EM, Bignall MC, Aaron BP, Underhill P, Lazar JM, Hudson DH.
    J Lab Clin Med; 1990 Oct 17; 116(4):516-26. PubMed ID: 2212861
    [Abstract] [Full Text] [Related]

  • 20. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
    Ehlert JE, Gerdes J, Flad HD, Brandt E.
    J Immunol; 1998 Nov 01; 161(9):4975-82. PubMed ID: 9794434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.